Pradhan P, Rajbhandari P, Nagaraja S B, Shrestha P, Grigoryan R, Satyanarayana S, Davtyan H
Department of Medical Microbiology and Immunology, Patan Academy of Health Sciences, Lalitpur, Nepal.
Department of Community Medicine, ESIC Medical College and Post Graduate Institute of Medical Science and Research, Bangalore, India.
Public Health Action. 2021 Nov 1;11(Suppl 1):46-51. doi: 10.5588/pha.21.0042.
Patan Hospital, Lalitpur, Nepal.
To describe 1) the prevalence of methicillin-resistant (MRSA) and its antibiotic sensitivity pattern; 2) the demographic and clinical characteristics associated with MRSA infections; and 3) the treatment outcomes of in-patients with MRSA infection among patients with infection between January 2018 and December 2020.
This was a cross-sectional study using electronic and paper-based hospital records of patients with infection.
Of the 1,804 patients with infection 1,027 patients (57%, 95% CI 55-59) had MRSA. The MRSA were susceptible to vancomycin (100%), linezolid (96%), doxycycline (96%), chloramphenicol (86%) and cotrimoxazole (70%), and resistant to erythromycin (68%), clindamycin (56%), gentamycin (58%), ciprofloxacin (92%) and ofloxacin (91%). The prevalence of MRSA was higher in 2019, among out-patients, and in respiratory samples, and lower in blood samples. Of the 142 in-patients with MRSA, 93% had a successful clinical outcome (cured/improved).
More than 50% of patients with infection had MRSA that were resistant to commonly available antibiotics. This calls for strengthening surveil-lance and good infection control practices in this hospital.
尼泊尔拉利特布尔的帕坦医院。
描述1)耐甲氧西林金黄色葡萄球菌(MRSA)的患病率及其抗生素敏感性模式;2)与MRSA感染相关的人口统计学和临床特征;3)2018年1月至2020年12月期间感染患者中MRSA感染住院患者的治疗结果。
这是一项横断面研究,使用感染患者的电子和纸质医院记录。
在1804例感染患者中,1027例(57%,95%CI 55 - 59)为MRSA。MRSA对万古霉素(100%)、利奈唑胺(96%)、强力霉素(96%)、氯霉素(86%)和复方新诺明(70%)敏感,对红霉素(68%)、克林霉素(56%)、庆大霉素(58%)、环丙沙星(92%)和氧氟沙星(91%)耐药。2019年门诊患者以及呼吸道样本中MRSA的患病率较高,血液样本中较低。在142例MRSA住院患者中,93%获得了成功的临床结果(治愈/改善)。
超过50%的感染患者感染了对常用抗生素耐药的MRSA。这就要求该医院加强监测并实施良好的感染控制措施。